Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas

Haematologica. 2022 Mar 1;107(3):755-758. doi: 10.3324/haematol.2021.280139.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Viral
  • BNT162 Vaccine
  • Humans
  • Immunity, Cellular
  • Lymphoma, B-Cell* / drug therapy
  • Vaccines*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Vaccines
  • BNT162 Vaccine